Although several studies have shown that PSMA is expressed in the vasculature of bladder cancer (33–35), these studies only examined limited samples, or did not analyze the association between vascular PSMA expression and clinicopathological features and prognosis systematically. This evidence concerns the gene FOLH1 and urinary bladder carcinoma.